subject area of
- A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma Academic Article
- A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial Academic Article
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis Academic Article
- Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial Academic Article
- Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practices Academic Article
- Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs Academic Article
- Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting. Academic Article
- Extracorporeal Photopheresis (ECP) in Patients with Steroid-dependent Crohnʼs Disease Academic Article
- Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2 and 3 Academic Article
- Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial Academic Article
- Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases Academic Article
- New Applications for Traditional Drugs in Inflammatory Bowel Disease Academic Article
- Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis Academic Article
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management Academic Article
- Segundo consenso europeo basado en evidencia sobre el diagnóstico y manejo de la colitis ulcerosa crónica idiopática. Parte 2: tratamiento actual (versión española) Academic Article
- Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis Academic Article
- Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease Academic Article
- Thalidomide-prednisone maintenance following autologous stem cell transplant for Multiple Myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10 Academic Article
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis Academic Article
- Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial Academic Article